• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    3/28/25 4:53:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care
    Get the next $RVP alert in real time by email

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2025 through March 31, 2025. The dividends will be paid on April 21, 2025 to shareholders of record as of the close of business on April 10, 2025.

    Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general line distributors.

    For more information on Retractable, visit its website at www.retractable.com.

    Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate. However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from such statements.

    Factors that could cause or contribute to such differences include, but are not limited to: material changes in demand, tariffs; Retractable's ability to maintain liquidity; Retractable's maintenance of patent protection; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements and relationships; foreign trade risk; Retractable's ability to access the market; production costs; the impact of larger market players in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange Commission.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250328446585/en/

    Retractable Technologies, Inc.

    John W. Fort III, 888-806-2626 or 972-294-1010

    Vice President, Chief Financial Officer, and Chief Accounting Officer

    Get the next $RVP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RVP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RVP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT AND CEO Shaw Thomas J bought $4,424 worth of shares (5,731 units at $0.77), increasing direct ownership by 0.04% to 15,831,222 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/17/25 11:29:38 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $81 worth of shares (100 units at $0.81), increasing direct ownership by 0.00% to 15,825,491 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/13/25 1:29:23 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $6,195 worth of shares (7,500 units at $0.83), increasing direct ownership by 0.05% to 15,825,391 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/6/25 10:53:09 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Retractable Technologies, Inc. Results for the Periods Ended September 30, 2025

    Retractable Technologies, Inc. (NYSE:RVP) reports total net sales of $10.1 million for the third quarter of 2025 and an operating loss of $3.7 million for the period, as compared to total net sales for the same period last year of $10.3 million and an operating loss of $5.1 million. For the first nine months of the year, net sales were $28.8 million and operating losses were $13.5 million as compared to 2024 net revenues of $24.0 million and operating losses of $13.9 million. Tariffs continue to have a material impact on our results of operation and financial position. The tariff rate on needles and syringes imported from China as of September 30, 2025 was 130% and the rate on other produ

    11/14/25 3:13:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Retractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle

    Retractable Technologies, Inc. (NYSE:RVP) announces its EasyPoint® Blood Collection Tube Holder with Needle has received an Innovative Technology designation from Vizient®, the largest healthcare performance improvement company in the country. Each year, healthcare experts serving on one of Vizient's client-led councils review select products and technologies for their potential to enhance clinical care, patient safety, healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers the impact of these innovations on patient care and business models of he

    11/14/25 2:49:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2025 through September 30, 2025. The dividends will be paid on October 20, 2025 to shareholders of record as of the close of business on October 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV

    9/30/25 2:06:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT AND CEO Shaw Thomas J bought $4,424 worth of shares (5,731 units at $0.77), increasing direct ownership by 0.04% to 15,831,222 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/17/25 11:29:38 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $81 worth of shares (100 units at $0.81), increasing direct ownership by 0.00% to 15,825,491 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/13/25 1:29:23 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $6,195 worth of shares (7,500 units at $0.83), increasing direct ownership by 0.05% to 15,825,391 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/6/25 10:53:09 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    SEC Filings

    View All

    Retractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)

    11/14/25 3:19:59 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Retractable Technologies Inc.

    10-Q - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)

    11/14/25 1:00:27 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Retractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)

    9/30/25 3:01:21 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    Leadership Updates

    Live Leadership Updates

    View All

    Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred Stock Shareholders

    LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $10,041 and $39,050, respectively. Over the entire accrual period, the dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from October 1, 2020 through date of conversion or December 31, 2020 whichever is applicable. The dividends will be paid on January 29, 2021. All Series I Class B Conv

    1/8/21 2:32:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    Financials

    Live finance-specific insights

    View All

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2025 through September 30, 2025. The dividends will be paid on October 20, 2025 to shareholders of record as of the close of business on October 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV

    9/30/25 2:06:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning April 1, 2025 through June 30, 2025. The dividends will be paid on July 21, 2025 to shareholders of record as of the close of business on July 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter

    6/30/25 2:04:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2025 through March 31, 2025. The dividends will be paid on April 21, 2025 to shareholders of record as of the close of business on April 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV cathe

    3/28/25 4:53:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $RVP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

    SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

    2/8/23 2:38:31 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

    SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

    5/2/22 4:33:55 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

    SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

    1/27/22 2:27:52 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care